NutraLife BioSciences, Inc. (NLBS)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0000 - 0.0400 - Volume
50 - Avg. Volume
48 - Market Cap (intraday)
17,662 - Beta (5Y Monthly) -1.11
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products. The company also offers other products, such as skincare and sanitizer products. NutraLife BioSciences, Inc. sells its products through nutralifebiosciences.com, as well as through private label distributors, online retailers, and retail outlets. The company was formerly known as NutraFuels, Inc. and changed its name to NutraLife BioSciences, Inc. in March 2019. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida.
www.nutralifebiosciences.com12
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: NLBS
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NLBS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NLBS
Valuation Measures
Market Cap
17.66k
Enterprise Value
2.70M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.03
Price/Book (mrq)
--
Enterprise Value/Revenue
4.28
Enterprise Value/EBITDA
-1.58
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-28.48%
Return on Equity (ttm)
--
Revenue (ttm)
631.96k
Net Income Avi to Common (ttm)
-3.99M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
431.71k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.13M